Evaluation of Blood Brain Barrier Permeability in Chronic Stroke

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2010 by Wolfson Medical Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Wolfson Medical Center
ClinicalTrials.gov Identifier:
NCT01203800
First received: September 15, 2010
Last updated: NA
Last verified: September 2010
History: No changes posted
  Purpose

In this study the investigators intend to explore the long term significance of BBB disruption on the clinical course and the rate of significant recurrent ischemic events in patients with a chronic stroke.


Condition
A Positive or a Negative Brain SPECT

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Evaluation of Blood Brain Barrier Permeability in Chronic Stroke

Further study details as provided by Wolfson Medical Center:

Primary Outcome Measures:
  • Blood Brain Barrier permeability [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Estimated Enrollment: 40
Study Start Date: September 2009
Estimated Study Completion Date: September 2011
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Male and female patients at any age with a history of a large stroke in the territory of the middle cerebral artery, occurring 1-2 years ago or between 2-5 years ago.

Criteria

Inclusion Criteria:

  • Male and female patients at any age with a history of a large stroke in the territory of the middle cerebral artery, occurring 1-2 years ago or between 2-5 years ago.

Exclusion Criteria:

  • Lacunar strokes,
  • CNS lesions other than a stroke,
  • unable to perform the study.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01203800

Contacts
Contact: Mordechai Lorberboym, M.D. 972-544-630930 lorberboym@wolfson.health.gov.il

Locations
Israel
Wolfson Medical Center Recruiting
Holon, Israel, 58100
Contact: Mordechai Lorberboym, M.D.    972-544630930      
Principal Investigator: Mordechai Lorberboym, M.D.         
Sponsors and Collaborators
Wolfson Medical Center
  More Information

No publications provided

Responsible Party: Mordechai Lorberboym, M.D., Edith Wolfson Medical Center
ClinicalTrials.gov Identifier: NCT01203800     History of Changes
Other Study ID Numbers: 0056-09-WOMC
Study First Received: September 15, 2010
Last Updated: September 15, 2010
Health Authority: Israel: Ministry of Health

ClinicalTrials.gov processed this record on October 20, 2014